Eric Lammertsma

Eric Lammertsma has a strong background in product management and leadership roles. Eric currently serves as the Interim Head of Product at Docflow, where they have been responsible for professionalizing and streamlining product management processes. Eric implemented a hybrid model of Agile and Shape-up methodologies, leading to a 20%+ increase in feature delivery speed. Eric also educated the founder and product team on product-led growth principles and developed a roadmap for implementation.

Prior to their current role, Eric was the Head of Product at Tilig, where they focused on refining design and development processes and increasing user retention. Eric oversaw a remote team and was appointed interim CEO within their first 90 days.

Eric also has experience as the Head of Product at Pixplicity, where they helped US-based clients develop innovative and technically challenging products. Eric coached clients on effective go-to-market strategies, resulting in a 220% increase in US business within the first two years. Eric also served as CEO and co-founder of Pixplicity, leading business development and establishing the company's competitive advantages.

Earlier in their career, Eric was the CEO and co-founder of CrimsonBase, spearheading product management for intelligent genetics software. Eric differentiated the software from competitors by implementing a user-friendly UX/UI rule.

Throughout their career, Eric has demonstrated a strong ability to drive product innovation, streamline processes, and achieve business growth.

Eric Lammertsma has a diverse educational background. Eric pursued a "Mini MBA" in Fundamentals of Business and Economics at Utrecht University, specializing in the field of business and economics. Additionally, they completed a Microbial Pathogenesis Internship at Yale University School of Medicine, focusing on the study of microbial diseases. At Utrecht University, Eric also embarked on coursework towards a Master of Science (MS) in Science and Business, further expanding their knowledge in the intersection of science and business. Prior to that, they obtained a Bachelor of Science (BS) in Biomedical Sciences, establishing a solid foundation in the field.